AAAAAA
Results:
1-25
|
Results: 25
Authors:
FEUSSNER G
FEUSSNER V
HOFFMANN MM
LOHRMANN J
WIELAND H
MARZ W
Citation: G. Feussner et al., MOLECULAR-BASIS OF TYPE-III HYPERLIPOPROTEINEMIA IN GERMANY, Human mutation, 11(6), 1998, pp. 417-423
Authors:
MARZ W
HOFFMANN MM
SCHARNAGL H
FISHER E
CHEN MC
NAUCK M
FEUSSNER G
WIELAND H
Citation: W. Marz et al., APOLIPOPROTEIN E2 (ARG(136)-]CYS) MUTATION IN THE RECEPTOR-BINDING DOMAIN OF APOE IS NOT ASSOCIATED WITH DOMINANT TYPE-III HYPERLIPOPROTEINEMIA, Journal of lipid research, 39(3), 1998, pp. 658-669
Authors:
REXIN M
FEUSSNER G
Citation: M. Rexin et G. Feussner, A COMPETITIVE REVERSE TRANSCRIPTION-PCR TO STUDY APOLIPOPROTEIN-EPSILON GENE-EXPRESSION, Clinical chemistry, 44(4), 1998, pp. 773-778
Authors:
DOBMEYER JM
REXIN M
DOBMEYER TS
KLEIN SA
ROSSOL R
FEUSSNER G
Citation: Jm. Dobmeyer et al., QUANTITATION OF APOLIPOPROTEIN-EPSILON GENE-EXPRESSION BY COMPETITIVEPOLYMERASE-CHAIN-REACTION IN A PATIENT WITH FAMILIAL APOLIPOPROTEIN-EDEFICIENCY, Clinica chimica acta, 274(2), 1998, pp. 119-137
Authors:
FEUSSNER G
PIESCH S
DOBMEYER J
FISCHER C
Citation: G. Feussner et al., GENETICS OF TYPE-III HYPERLIPOPROTEINEMIA, Genetic epidemiology, 14(3), 1997, pp. 283-297
Authors:
FEUSSNER G
FEUSSNER V
LOHRMANN J
HOFFMANN MM
WIELAND H
MARZ W
Citation: G. Feussner et al., MOLECULAR-BASIS OF TYPE-III HYPERLIPOPROTEINEMIA (HLP), Atherosclerosis, 134(1-2), 1997, pp. 67-67
Authors:
EICHINGER M
LOHRMANN J
FEUSSNER V
FEUSSNER G
Citation: M. Eichinger et al., SIGNIFICANTLY DECREASED FREQUENCY OF A COMMON MUTATION IN THE METHYLENETETRAHYDROFOLATE REDUCTASE (MTHFR) GENE IN PATIENTS WITH TYPE-III HYPERLIPOPROTEINEMIA (HLP), Atherosclerosis, 134(1-2), 1997, pp. 67-67
Authors:
FEUSSNER G
REXIN M
Citation: G. Feussner et M. Rexin, A REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION (RT-PCR) BASED METHOD TO STUDY APOLIPOPROTEIN (APO)-EPSILON GENE-EXPRESSION, Atherosclerosis, 134(1-2), 1997, pp. 67-67
Authors:
SCHARNAGL H
FEUSSNER G
ACAR J
WIELAND H
MARZ W
Citation: H. Scharnagl et al., APOLIPOPROTEIN-E DEFICIENT REMNANT LIPOPROTEINS AND RECOMBINANT APOLIPOPROTEIN-E - A NEW MODEL TO CHARACTERIZE THE INTERACTION OF APOLIPOPROTEIN-E WITH LIPOPROTEIN RECEPTORS AND PROTEOGLYCANS, Atherosclerosis, 134(1-2), 1997, pp. 361-361
Authors:
FEUSSNER G
DOBMEYER J
NISSEN H
HANSEN TS
Citation: G. Feussner et al., UNUSUAL XANTHOMAS IN A YOUNG PATIENT WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA AND TYPE-III HYPERLIPOPROTEINEMIA, American journal of medical genetics, 65(2), 1996, pp. 149-154
Authors:
FEUSSNER G
SCHARNAGL H
SCHERBAUM C
ACAR J
DOBMEYER J
LOHRMANN J
WIELAND H
MARZ W
Citation: G. Feussner et al., APOLIPOPROTEIN E5 (GLU(212)-]LYS) - INCREASED BINDING TO CELL-SURFACEPROTEOGLYCANS BUT DECREASED UPTAKE AND LYSOSOMAL DEGRADATION IN CULTURED FIBROBLASTS, Journal of lipid research, 37(8), 1996, pp. 1632-1645
Authors:
FEUSSNER G
Citation: G. Feussner, SEVERE XANTHOMATOSIS ASSOCIATED WITH FAMILIAL APOLIPOPROTEIN-E DEFICIENCY, Journal of Clinical Pathology, 49(12), 1996, pp. 985-989
Authors:
FEUSSNER G
ALBANESE M
VALENCIA A
Citation: G. Feussner et al., 3-DIMENSIONAL STRUCTURE OF THE LDL RECEPTOR-BINDING DOMAIN OF THE HUMAN APOLIPOPROTEIN E2 (ARG(136)-]CYS) VARIANT, Atherosclerosis, 126(2), 1996, pp. 177-184
Authors:
DOBMEYER J
LOHRMANN J
FEUSSNER G
Citation: J. Dobmeyer et al., PREVALENCE AND ASSOCIATION OF ATHEROSCLEROSIS AT 3 DIFFERENT ARTERIALSITES IN PATIENTS WITH TYPE-III HYPERLIPOPROTEINEMIA, Atherosclerosis, 119(1), 1996, pp. 89-98
Authors:
FEUSSNER G
ALBANESE M
MANN WA
VALENCIA A
SCHUSTER H
Citation: G. Feussner et al., APOLIPOPROTEIN E2 (ARG-136-]CYS), A VARIANT OF APOLIPOPROTEIN-E ASSOCIATED WITH LATE-ONSET DOMINANCE OF TYPE-III HYPERLIPOPROTEINEMIA, European journal of clinical investigation, 26(1), 1996, pp. 13-23
Authors:
FEUSSNER G
DOBMEYER J
GRONE HJ
LOHMER S
WOHLFEIL S
Citation: G. Feussner et al., A 10-BP DELETION IN THE APOLIPOPROTEIN-EPSILON GENE CAUSING APOLIPOPROTEIN-E DEFICIENCY AND SEVERE TYPE-III HYPERLIPOPROTEINEMIA, American journal of human genetics, 58(2), 1996, pp. 281-291
Authors:
FISHER RM
MAILLY F
PEACOCK RE
HAMSTEN A
SEED M
YUDKIN JS
BEISIEGEL U
FEUSSNER G
MILLER G
HUMPHRIES SE
TALMUD PJ
Citation: Rm. Fisher et al., INTERACTION OF THE LIPOPROTEIN-LIPASE ASPARAGINE-291-]SERINE MUTATIONWITH BODY-MASS INDEX DETERMINES ELEVATED PLASMA TRIACYLGLYCEROL CONCENTRATIONS - A STUDY IN HYPERLIPIDEMIC SUBJECTS, MYOCARDIAL-INFARCTION SURVIVORS, AND HEALTHY-ADULTS, Journal of lipid research, 36(10), 1995, pp. 2104-2112
Authors:
FEUSSNER G
LOHRMANN J
DOBMEYER J
Citation: G. Feussner et al., RAPID AND RELIABLE IDENTIFICATION OF HUMAN APOLIPOPROTEIN E1 (GLY(127)-]ASP, ARG(158)-]CYS) VARIANT, Clinical chemistry, 41(7), 1995, pp. 1043-1045
Authors:
FEUSSNER G
FEUSSNER V
ZIEGLER R
Citation: G. Feussner et al., APOLIPOPROTEIN (A) PHENOTYPES AND LIPOPROTEIN (A) CONCENTRATIONS IN PATIENTS WITH TYPE-III HYPERLIPOPROTEINEMIA, Journal of internal medicine, 235(5), 1994, pp. 425-430
Authors:
FEUSSNER G
STECH C
DOBMEYER J
SCHAEFER H
OTTO G
ZIEGLER R
Citation: G. Feussner et al., SERUM AMYLOID-A PROTEIN (SAA) - A MARKER FOR LIVER ALLOGRAFT-REJECTION IN HUMANS, The Clinical investigator, 72(12), 1994, pp. 1007-1011
Authors:
FEUSSNER G
FEUSSNER V
BOMMER J
GRUTZMACHER P
ZIEGLER R
Citation: G. Feussner et al., TYPE-III HYPERLIPOPROTEINEMIA AND RENAL-DISEASE, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 4(2), 1994, pp. 96-100
Authors:
FEUSSNER G
FEUSSNER V
ZIEGLER R
Citation: G. Feussner et al., LIPOPROTEIN(A) [LP(A)] - A GENETIC RISK F ACTOR FOR ARTERIOSCLEROSIS, Medizinische Klinik, 89(4), 1994, pp. 198-203
Authors:
FEUSSNER G
WAGNER A
KOHL B
ZIEGLER R
Citation: G. Feussner et al., CLINICAL-FEATURES OF TYPE-III HYPERLIPOPROTEINEMIA - ANALYSIS OF 64 PATIENTS, The Clinical investigator, 71(5), 1993, pp. 362-366
Authors:
MARZ W
FEUSSNER G
SIEKMEIER R
DONNERHAK B
SCHAAF L
RUZICKA V
GROSS W
Citation: W. Marz et al., APOLIPOPROTEIN-E TO APOLIPOPROTEIN-B RATIO - A MARKER FOR TYPE-III HYPERLIPOPROTEINEMIA, European journal of clinical chemistry and clinical biochemistry, 31(11), 1993, pp. 743-747
Authors:
FEUSSNER G
WAGNER A
ZIEGLER R
Citation: G. Feussner et al., RELATION OF CARDIOVASCULAR RISK-FACTORS TO ATHEROSCLEROSIS IN TYPE-III HYPERLIPOPROTEINEMIA, Human genetics, 92(2), 1993, pp. 122-126
Risultati:
1-25
|